Vytrus Biotech First Half 2024 Earnings: EPS: €0.068 (vs €0.053 in 1H 2023)

Simply Wall St · 10/16 04:11

Vytrus Biotech (BME:VYT) First Half 2024 Results

Key Financial Results

  • Revenue: €3.03m (up 21% from 1H 2023).
  • Net income: €510.7k (up 42% from 1H 2023).
  • Profit margin: 17% (up from 14% in 1H 2023). The increase in margin was driven by higher revenue.
  • EPS: €0.068 (up from €0.053 in 1H 2023).
earnings-and-revenue-history
BME:VYT Earnings and Revenue History October 16th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Vytrus Biotech shares are up 1.8% from a week ago.

Risk Analysis

You should always think about risks. Case in point, we've spotted 2 warning signs for Vytrus Biotech you should be aware of.